Publicaciones en colaboración con investigadores/as de Hospital Universitario Virgen de las Nieves (24)

2024

  1. Chronic obstructive pulmonary disease mortality in Spain between 1999 and 2019

    Medicina Clinica, Vol. 162, Núm. 1, pp. 9-14

  2. Detection of Alpha-1 Antitrypsin Levels in Chronic Obstructive Pulmonary Disease in Respiratory Clinics in Spain: Results of the EPOCONSUL 2021 Audit

    Journal of Clinical Medicine, Vol. 13, Núm. 4

  3. Multidisciplinary Management of Patients With Chronic Obstructive Pulmonary Disease and Cardiovascular Disease

    Archivos de Bronconeumologia, Vol. 60, Núm. 4, pp. 226-237

2023

  1. Inhaled Maintenance Therapy in the Follow-Up of COPD in Outpatient Respiratory Clinics. Factors Related to Inhaled Corticosteroid Use. EPOCONSUL 2021 Audit

    Archivos de Bronconeumologia, Vol. 59, Núm. 11, pp. 725-735

  2. Inhaler Adherence in COPD: A Crucial Step Towards the Correct Treatment

    International journal of chronic obstructive pulmonary disease, Vol. 18, pp. 2887-2893

  3. Mortality risk reduction with budesonide/glycopyrrolate/formoterol fumarate versus fluticasone furoate/umeclidinium/vilanterol in COPD: a matching-adjusted indirect comparison based on ETHOS and IMPACT

    Current Medical Research and Opinion, Vol. 39, Núm. 10, pp. 1395-1405

  4. Variations in Chronic Obstructive Pulmonary Disease Outpatient Care in Respiratory Clinics: Results From the 2021 EPOCONSUL Audit

    Archivos de Bronconeumologia, Vol. 59, Núm. 5, pp. 295-304

2022

  1. ANTES Program: One Year on

    Archivos de Bronconeumologia

  2. Clinical Characteristics, Treatment Persistence, and Outcomes Among Patients With COPD Treated With Single- or Multiple-Inhaler Triple Therapy: A Retrospective Analysis in Spain

    Chest, Vol. 162, Núm. 5, pp. 1017-1029

  3. Pulmonologists’ Opinion on the Use of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease Patients in Spain: A Cross-Sectional Survey

    International Journal of COPD, Vol. 17, pp. 1577-1587

  4. Segmentectomy in Lung Cancer as a New Standard of Treatment: Can Less Be More?

    Archivos de Bronconeumologia

  5. T2 Biomarkers as Predictors of Exacerbations of Chronic Obstructive Pulmonary Disease

    Archivos de Bronconeumologia, Vol. 58, Núm. 8, pp. 595-600

  6. Use of Antivirals in SARS-CoV-2 Infection. Critical Review of the Role of Remdesivir

    Drug design, development and therapy, Vol. 16, pp. 827-841

  7. [Translated article] ANTES Program: One Year on

    Archivos de Bronconeumologia

  8. [Translated article] Biological Biomarkers in Respiratory Diseases

    Archivos de Bronconeumologia

2021

  1. Burden of disease among exacerbating patients with COPD treated with triple therapy in Spain

    International Journal of COPD, Vol. 16, pp. 2149-2161

2020

  1. Personalized Medicine in Chronic Obstructive Pulmonary Disease: How Close Are We?

    Archivos de Bronconeumologia, Vol. 56, Núm. 7, pp. 420-421

  2. Small cell lung cancer: Recent changes in clinical presentation and prognosis

    Clinical Respiratory Journal, Vol. 14, Núm. 3, pp. 222-227

2018

  1. Changes in non-small cell lung cancer diagnosis, molecular testing and prognosis 2011-2016

    Journal of Thoracic Disease, Vol. 10, Núm. 9, pp. 5468-5475

2016

  1. Validation of the 'Test of the Adherence to Inhalers' (TAI) for Asthma and COPD Patients

    Journal of Aerosol Medicine and Pulmonary Drug Delivery, Vol. 29, Núm. 2, pp. 142-152